Shufro Rose & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41.3M | Sell |
44,944
-161
| -0.4% | -$163K | 2.81% | 7 |
|
|
2025
Q4 | $48.5M | Buy |
45,105
+21
| +0% | +$20.1K | 3.28% | 8 |
|
|
2025
Q3 | $37.2M | Hold |
45,084
| – | – | 3.04% | 8 |
|
|
2025
Q2 | $37.2M | Sell |
45,084
-30
| -0.1% | -$23.3K | 2.99% | 8 |
|
|
2025
Q1 | $37.3M | Sell |
45,114
-600
| -1% | -$499K | 2.94% | 8 |
|
|
2024
Q4 | $35.3M | Sell |
45,714
-2,037
| -4% | -$1.69M | 2.73% | 9 |
|
|
2024
Q3 | $43.2M | Hold |
47,751
| – | – | 3.51% | 4 |
|
|
2024
Q2 | $43.2M | Buy |
47,751
+2,167
| +5% | +$1.73M | 3.51% | 4 |
|
|
2024
Q1 | $35.5M | Sell |
45,584
-5
| -0% | -$3.56K | 2.93% | 6 |
|
|
2023
Q4 | $24.5M | Hold |
45,589
| – | – | 2.32% | 14 |
|
|
2023
Q3 | $24.5M | Sell |
45,589
-5
| -0% | -$2.58K | 2.31% | 14 |
|
|
2023
Q2 | $21.4M | Sell |
45,594
-410
| -0.9% | -$172K | 1.95% | 17 |
|
|
2023
Q1 | $15.8M | Sell |
46,004
-362
| -0.8% | -$122K | 1.46% | 21 |
|
|
2022
Q4 | $17M | Buy |
46,366
+4
| +0% | +$1.42K | 1.43% | 23 |
|
|
2022
Q3 | $15M | Buy |
46,362
+107
| +0.2% | +$33.9K | 1.5% | 21 |
|
|
2022
Q2 | $15M | Sell |
46,255
-20
| -0% | -$6K | 1.3% | 24 |
|
|
2022
Q1 | $13.3M | Buy |
46,275
+102
| +0.2% | +$26.3K | 1.02% | 26 |
|
|
2021
Q4 | $12.8M | Hold |
46,173
| – | – | 0.92% | 32 |
|
|
2021
Q3 | $10.7M | Buy |
46,173
+20
| +0% | +$4.94K | 0.84% | 36 |
|
|
2021
Q2 | $10.6M | Hold |
46,153
| – | – | 0.8% | 36 |
|
|
2021
Q1 | $8.62M | Hold |
46,153
| – | – | 0.68% | 37 |
|
|
2020
Q4 | $7.79M | Sell |
46,153
-210
| -0.5% | -$31.4K | 0.65% | 41 |
|
|
2020
Q3 | $6.86M | Buy |
46,363
+251
| +0.5% | +$38.8K | 0.66% | 39 |
|
|
2020
Q2 | $7.57M | Hold |
46,112
| – | – | 0.75% | 37 |
|
|
2020
Q1 | $6.4M | Hold |
46,112
| – | – | 0.76% | 36 |
|
|
2019
Q4 | $6.06M | Sell |
46,112
-702
| -1% | -$81.4K | 0.55% | 43 |
|
|
2019
Q3 | $5.24M | Sell |
46,814
-43
| -0.1% | -$4.79K | 0.52% | 47 |
|
|
2019
Q2 | $5.19M | Buy |
46,857
+43
| +0.1% | +$5.06K | 0.51% | 49 |
|
|
2019
Q1 | $6.08M | Sell |
46,814
-155
| -0.3% | -$18.8K | 0.61% | 47 |
|
|
2018
Q4 | $5.43M | Sell |
46,969
-65
| -0.1% | -$7.26K | 0.6% | 45 |
|
|
2018
Q3 | $5.05M | Hold |
47,034
| – | – | 0.47% | 60 |
|
|
2018
Q2 | $4.01M | Hold |
47,034
| – | – | 0.38% | 68 |
|
|
2018
Q1 | $3.64M | Sell |
47,034
-1,189
| -2% | -$95.7K | 0.36% | 69 |
|
|
2017
Q4 | $4.07M | Sell |
48,223
-477
| -1% | -$40.6K | 0.4% | 60 |
|
|
2017
Q3 | $4.17M | Sell |
48,700
-455
| -0.9% | -$37.3K | 0.42% | 59 |
|
|
2017
Q2 | $4.04M | Sell |
49,155
-300
| -0.6% | -$24.5K | 0.43% | 57 |
|
|
2017
Q1 | $4.16M | Sell |
49,455
-900
| -2% | -$72.1K | 0.45% | 53 |
|
|
2016
Q4 | $3.7M | Sell |
50,355
-645
| -1% | -$48K | 0.41% | 58 |
|
|
2016
Q3 | $4.09M | Sell |
51,000
-337
| -0.7% | -$27K | 0.46% | 56 |
|
|
2016
Q2 | $4.04M | Sell |
51,337
-4,418
| -8% | -$333K | 0.45% | 58 |
|
|
2016
Q1 | $4.01M | Buy |
55,755
+3,718
| +7% | +$281K | 0.45% | 60 |
|
|
2015
Q4 | $4.38M | Sell |
52,037
-663
| -1% | -$55K | 0.5% | 55 |
|
|
2015
Q3 | $4.41M | Sell |
52,700
-644
| -1% | -$54.4K | 0.53% | 55 |
|
|
2015
Q2 | $4.45M | Hold |
53,344
| – | – | 0.47% | 59 |
|
|
2015
Q1 | $3.88M | Hold |
53,344
| – | – | 0.4% | 68 |
|
|
2014
Q4 | $3.68M | Buy |
+53,344
| New | +$3.6M | 0.37% | 71 |
|
|
2014
Q2 | – | Sell |
-4,100
| Closed | -$241K | – | 265 |
|
|
2014
Q1 | $241K | Sell |
4,100
-2
| -0% | -$112 | 0.03% | 217 |
|
|
2013
Q4 | $209K | Buy |
+4,102
| New | +$205K | 0.02% | 235 |
|
|
2013
Q3 | – | Sell |
-4,100
| Closed | -$201K | – | 258 |
|
|
2013
Q2 | $201K | Buy |
+4,100
| New | +$223K | 0.02% | 226 |
|
Other funds holding LLY
VCM
VPM
Shufro Rose & Co's LLY Position: Q1 2026 in Review
Shufro Rose & Co reduced its Eli Lilly (LLY) stake by 0.36% in Q1 2026, selling an estimated $163K and leaving 44,944 shares worth $41.3M. The position accounts for 2.81% of the portfolio, ranked #7.
Shufro Rose & Co first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $48.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Shufro Rose & Co held 44,944 shares of Eli Lilly worth $41.3M as of Q1 2026.
- Shufro Rose & Co sold 161 Eli Lilly shares in Q1 2026, an estimated $163K.
- Eli Lilly made up 2.81% of Shufro Rose & Co's portfolio in Q1 2026, its #7 holding.
- Shufro Rose & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
- Shufro Rose & Co's Eli Lilly position peaked at $48.5M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.